Latest Technology Platform News

HUB24 delivered a standout FY26 with record net inflows of $18.9 billion, a 20% rise excluding large migrations, and boosted total Funds Under Administration to $164.3 billion. The platform’s adviser base grew 11%, while new product launches and AI-driven tools expanded its market footprint.

Iondrive appoints ex-BHP innovation chief Dr Grant Caffery as CEO, signalling a pivot from development to commercial scale-up following strong rare earth recovery results and a US$15 million Oklahoma funding pathway.

Ovanti appoints two early Afterpay executives to its Advisory Board as it prepares to relaunch its BNPL platforms IOUPAY and myIOU, targeting rapid growth in Southeast Asia and beyond.

Jcurve Solutions delivered a standout FY26 with a 178% jump in EBITDA and an 18% rise in annual recurring revenue, setting the stage for further growth in FY27.

AdNeo’s subsidiary Catapult Education has been appointed to a multi-year contract with TAFE South Australia to supply vocational education content, supporting newly funded National Centres of Excellence in Early Childhood Education and National Security.

Bridge SaaS Limited has exited its non-core investment in Brightside Disability Support, recouping its initial outlay and sharpening its focus on AI-driven disability services and robotics innovation.

Temas Resources has filed a new patent for extracting chromium using its Regenerative Chloride Leach technology, broadening its critical minerals platform and commercial prospects.

Orthocell Limited has posted record revenue for FY2026, driven by strong sales growth of Remplir™ and Striate+™ products in Australia, the US, and new international markets, supported by a robust $44.1 million cash position.

Noxopharm has taken a key regulatory step by requesting a pre-IND meeting with the US FDA for its autoimmune drug candidate SOF-SKN, aiming to smooth the path for clinical development and boost its commercial appeal.

HALO Technologies launches a convertible notes offer aiming to raise up to A$6.75 million, backing platform upgrades and expansion across Asia-Pacific and adviser networks.

Lumos Diagnostics has received a A$709,837 cash refund from the Australian Government’s R&D Tax Incentive, bolstering its investment in proprietary point-of-care diagnostic technologies.

Talius has landed a $1.15 million contract with Seventh-day Adventist Aged Care (North NSW), doubling its recent Queensland deal and adding over $100,000 in annual recurring revenue.